Last reviewed · How we verify

Amoxicillin 1 g

Rehman Medical Institute - RMI · FDA-approved active Small molecule Quality 5/100

Amoxicillin 1 g is a Small molecule drug developed by Rehman Medical Institute - RMI. It is currently FDA-approved.

At a glance

Generic nameAmoxicillin 1 g
SponsorRehman Medical Institute - RMI
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Amoxicillin 1 g

What is Amoxicillin 1 g?

Amoxicillin 1 g is a Small molecule drug developed by Rehman Medical Institute - RMI.

Who makes Amoxicillin 1 g?

Amoxicillin 1 g is developed and marketed by Rehman Medical Institute - RMI (see full Rehman Medical Institute - RMI pipeline at /company/rehman-medical-institute-rmi).

What development phase is Amoxicillin 1 g in?

Amoxicillin 1 g is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing